SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is trending as the community speculates on upcoming AI-driven utility and ecosystem expansions, with many investors actively loading up on positions to lower their cost basis during current consolidation. Enthusiasts are highlighting the project's large holder count and long-term potential, maintaining a bullish outlook while awaiting a significant catalyst to drive the next breakout.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is currently trending as investors weigh significant institutional interest and potential sector-wide gene editing advancements against ongoing concerns regarding high cash burn and the slow pace of commercial rollouts. The community remains deeply divided, actively debating whether the stock is a long-term disruptor primed for a breakout or a stagnant asset struggling with management execution and excessive share dilution.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investors rotate into high-yield, defensive healthcare stocks amidst broader market volatility, while the company also continues to aggressively pursue oncology M&A to address long-term patent concerns. The community remains focused on Merck's strategic deal-making and its role as a stable anchor in portfolios currently shifting away from momentum-heavy sectors.

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Domestic Operations and International Operations segments. The company was founded on November 13, 2014 and is headquartered in Stamford, CT.

Curaleaf Holdings Inc

Curaleaf investors are closely monitoring the DEA's upcoming administrative hearings on potential cannabis rescheduling, fueling speculation about the industry's legislative future. The community is actively debating the company's competitive advantages in international markets and its growth potential, while navigating concerns over recent corporate restructuring actions.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

The Health Care Select Sector SPDR Fund ($XLV) is currently experiencing increased capital inflows as market participants rotate out of overextended technology and growth sectors into more defensive positions. Investors are closely monitoring the sector's technical breakout levels and individual constituents like Eli Lilly as they look for stability and durable demand in an uncertain macro environment.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: PepsiCo Foods North America (PFNA), PepsiCo Beverages North America (PBNA), International Beverages Franchise (IB Franchise), Europe, Middle East and Africa (EMEA), Latin America Foods (LatAm Foods), and Asia Pacific Foods. The PFNA segment refers to the food businesses in the United States and Canada. The PBNA segment includes beverage businesses in the United States and Canada. The IB Franchise segment involves the international franchise beverage businesses, as well as the SodaStream business. The EMEA segment pertains to food businesses and beverage businesses with company-owned bottlers in Europe, the Middle East, and Africa. The LatAm Foods segment consists of food businesses in Latin America. The Asia Pacific Foods segment is associated in food businesses in Asia Pacific, including China, Australia and New Zealand, as well as India. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

PepsiCo is trending as investors weigh its defensive strengths and dividend growth against ongoing challenges in beverage volume and consumer pricing sensitivity. The community remains focused on potential strategic acquisitions, management's brand innovation efforts, and the stock's resilience relative to broader market volatility.

Chip

Chip is trending as investors debate its role as a governance token for USD.AI, a protocol focused on GPU-backed lending for AI infrastructure. The community is sharply divided, with bulls pointing to protocol revenue and institutional interest as drivers for growth, while critics argue the token suffers from heavy sell pressure and insider dumping.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is facing intensified volatility as investors weigh the potential impacts of proposed federal interest rate caps on credit card products and legislative efforts to increase competition in the payment network space. Despite regulatory headwinds causing short-term selling pressure, the community remains actively divided between those concerned about structural margin compression and long-term holders treating the pullback as a prime accumulation opportunity for a high-quality global compounder.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the following segments: Square and Cash App. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Block Inc. is surging following the announcement of a major restructuring plan that includes cutting 40% of its workforce, a move investors are interpreting as a strategic push toward AI-driven efficiency and improved profit margins. The market sentiment is heavily focused on this aggressive cost-cutting shift as a potential turning point for the company, while the community remains divided over whether the move is a visionary pivot or a desperate attempt to cover up underlying business challenges.

Dogelon Mars

Dogelon Mars continues to trend as investors debate its long-term potential, with community members actively comparing the project to other meme coins while calling for strategic token burns to boost visibility. Sentiment remains polarized between those hoping for a speculative breakout and those frustrated by historical price performance and a lack of clear development updates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Notable Labs Ltd. is a clinical-stage platform therapeutics company that develops predictive medicines for patients with cancer. Through its proprietary Predictive Medicines Platform, the firm predicts whether or not that patient is likely to respond to that specific therapeutic. The company's Predictive Medicines Platform is designed to identify and select patients expected to be clinically responsive prior to their treatment to improve patient outcomes and fast-track clinical development. The firm's product candidate, Volasertib, is a Polo-like Kinase 1 inhibitor. Notable Labs was founded on January 31, 2000 and is headquartered in Foster City, CA.

Notable Labs Ltd

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

NTBLVascular Biogenics Ltd

Latest NTBL News